Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders

[1]  S. Basu,et al.  Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PET. , 2009, Clinical nuclear medicine.

[2]  A. Alavi,et al.  Potential of Dual Time Point FDG-PET Imaging in Differentiating Malignant from Benign Pleural Disease , 2009, Molecular Imaging and Biology.

[3]  P. Feustel,et al.  Bilateral Hilar Foci on 18F-FDG PET Scan in Patients Without Lung Cancer: Variables Associated with Benign and Malignant Etiology , 2008, Journal of Nuclear Medicine.

[4]  A. Heinzel,et al.  Assessment of Large-Vessel Involvement in Giant Cell Arteritis with 18F-FDG PET: Introducing an ROC-Analysis–Based Cutoff Ratio , 2008, Journal of Nuclear Medicine.

[5]  A. Constantinesco,et al.  18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  B. Weynand,et al.  EUS-FNA and FDG-PET are complementary procedures in the diagnosis of enlarged mediastinal lymph nodes. , 2008, Acta gastro-enterologica Belgica.

[7]  A. Alavi,et al.  FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  H. Macapinlac,et al.  The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. , 2008, Medical mycology.

[9]  J. Gossage,et al.  Malignancy in Kaolin Pneumoconiosis Found With F-18 FDG Positron Emission Tomography , 2008, Clinical nuclear medicine.

[10]  T. Shim,et al.  Evaluation of Therapeutic Response of Tuberculoma Using F-18 FDG Positron Emission Tomography , 2008, Clinical nuclear medicine.

[11]  T. Shiga,et al.  Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis , 2007, Annals of nuclear medicine.

[12]  A. Alavi,et al.  Etiopathologies Associated with Intercostal Muscle Hypermetabolism and Prominent Right Ventricle Visualization on 2-Deoxy-2[F-18]fluoro-d-glucose-Positron Emission Tomography: Significance of an Incidental Finding and in the Setting of a Known Pulmonary Disease , 2007, Molecular Imaging and Biology.

[13]  A. Alavi,et al.  Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. , 2007, Clinical nuclear medicine.

[14]  S. Goldman,et al.  Papillary muscle inflammation in Takayasu's arteritis revealed by FDG-PET. , 2007, European heart journal.

[15]  Abass Alavi,et al.  Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. , 2006, Nuclear medicine and biology.

[16]  P. Tchou,et al.  Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques , 2006, European Respiratory Journal.

[17]  L. Mortelmans,et al.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. , 2006, Arthritis and rheumatism.

[18]  Z. Win,et al.  FDG-PET imaging in Pneumocystis carinii pneumonia. , 2005, Clinical nuclear medicine.

[19]  W. Oyen,et al.  Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  Christian Schindler,et al.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  T. Yokoyama,et al.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of Nuclear Medicine.

[22]  J. Monteil,et al.  Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases , 2004, European Respiratory Journal.

[23]  M. Kennedy,et al.  Progressive massive fibrosis secondary to pulmonary silicosis appearance on F-18 fluorodeoxyglucose PET/CT. , 2004, Clinical nuclear medicine.

[24]  M. Yoshiyama,et al.  Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation , 2004, Heart.

[25]  E. Henze,et al.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study , 2004, Annals of the rheumatic diseases.

[26]  R. Coleman,et al.  Positron Emission Tomography With Fluoro-2-deoxy-D-glucose (FDG-PET) in the Staging of Post Transplant Lymphoproliferative Disorder in Lung Transplant Recipients , 2004, Journal of thoracic imaging.

[27]  D. Schuster,et al.  Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[28]  T. Kaminaga,et al.  The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. , 2004, International journal of cardiology.

[29]  A. Al-nahhas,et al.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  Y. Nishiyama,et al.  A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography , 2003, Annals of nuclear medicine.

[31]  Shun‐ichi Watanabe,et al.  Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. , 2003, Anticancer research.

[32]  M. Yoshiyama,et al.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  N. Morrell,et al.  In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma , 2003, European Respiratory Journal.

[35]  Abass Alavi,et al.  Positron emission tomography imaging in nonmalignant thoracic disorders. , 2002, Seminars in nuclear medicine.

[36]  S. Treves,et al.  Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  M. Hara,et al.  FDG-PET findings in sclerosing hemangioma of the lung: a case report. , 2001, Radiation medicine.

[38]  H. Kiat,et al.  Fluorine-18 FDG Dual-Head Gamma Camera Coincidence Imaging of Radiation Pneumonitis , 2000, Clinical nuclear medicine.

[39]  E. Nitzsche,et al.  Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET , 2000, Annals of the rheumatic diseases.

[40]  N. Münchow,et al.  Fokussuche bei Patienten mit Fieber unklarer Genese: Ist die Positronen-Emissions-Tomographie mit F-18-Fluordesoxyglukose hilfreich? , 1999 .

[41]  J. Nuyts,et al.  New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. , 1999, Rheumatology.

[42]  H. Steinert,et al.  Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. , 1998, Blood.

[43]  S M Bakheet,et al.  Benign causes of 18-FDG uptake on whole body imaging. , 1998, Seminars in nuclear medicine.

[44]  E. Nitzsche,et al.  Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study , 1998 .

[45]  E. Nitzsche,et al.  Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study , 1998, Lupus.

[46]  T. Terada.  [Magnetic resonance imaging in neuro-Behçet's disease--comparison with clinical, X-ray CT, and PET findings]. , 1991, Ryumachi. [Rheumatism].

[47]  G. Meyer,et al.  [Imaging diagnosis of central nervous system involvement in panarteritis nodosa]. , 1989, Zeitschrift für Rheumatologie (Print).

[48]  O. Schober,et al.  [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI]. , 1989, Nuklearmedizin. Nuclear medicine.

[49]  F. Shishido,et al.  Sequential PET studies in neuro-behcet's syndrome , 1989, Journal of Neurology.

[50]  O. Schober,et al.  Cerebral involvement in systemic lupus erythematosus (SLE): Comparison of positron emission tomography (PET) with other imaging methods , 1989, Psychiatry Research.

[51]  P E Palmer,et al.  Pulmonary tuberculosis--usual and unusual radiographic presentations. , 1979, Seminars in roentgenology.

[52]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[53]  S. Sochocky.  Tuberculoma of the lung. , 1958, American review of tuberculosis.

[54]  N. Kobayashi,et al.  Pneumoconiosis associated with an esophageal ulcer and uptake revealed in FDGPET. , 2006, Internal medicine.

[55]  石丸 伸司.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis , 2005 .

[56]  H. Hundeshagen,et al.  PET and MR imaging in a neuro-behçet syndrome , 2004, European Journal of Nuclear Medicine.

[57]  A. Alavi,et al.  18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.

[58]  윤미진.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001 .

[59]  P. Goodman,et al.  FDG-PET finding in early-phase Takayasu arteritis. , 1999, Journal of computer assisted tomography.

[60]  R. Buchert,et al.  [A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful?]. , 1999, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[61]  R. Wunderink.  Mortality and the diagnosis of ventilator-associated pneumonia: a new direction. , 1998, American journal of respiratory and critical care medicine.

[62]  O. Schober,et al.  Einsatz der FDG-PET bei der Diagnostik des zentralnervösen Lupus erythematodes und Vergleich mit CT und MRI , 1989, Nuklearmedizin.